ArticleAnalytical and bioanalytical chemistry2025
Size-exclusion chromatography with post-column nucleic acid staining and fluorescence detection for sensitive ribonucleic acid analysis.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From nucleotides to intact transcripts through oligonucleotides: Integrated chromatographic strategies for therapeutic mRNA characterization.Analytical and bioanalytical chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA-based therapeutics, such as vaccines or gene therapy applications, are steadily gaining in popularity and require extensive analytical characterization with several orthogonal methods to ensure highest purity for safe use. In this study, size-exclusion chromatography (SEC) with multiple detectors was used for characterizing single- and double-stranded (ss/ds) RNA ladders, providing insights into how conformation and viscosity affect the different elution profiles observed for both species in SEC. Furthermore, high-resolution chromatographic separation was merged with the high-sensitivity detection provided by fluorescent dyes by developing an innovative approach relying on SEC with post-column nucleic acid staining and fluorescence detection (SEC-pcs-FLD). Herein, SEC-pcs-FLD was successfully applied to four out of five investigated dyes, namely SYBR Gold, SYBR Green I, Thiazole Orange, and YOYO-1, yielding a 10- to 150-fold sensitivity increase for mRNA detection compared to typically applied UV detection for chromatographic nucleic acid analysis. Besides the significant sensitivity increase, reproducibility and linearity regarding the response to concentration ratio were demonstrated for the post-column staining approach, indicating suitability for low-level RNA quantitation. Two of the investigated dyes, namely SYBR Green I and YOYO-1, further allowed for the differentiation of ssRNA and dsRNA species based on SEC-pcs-FLD, as they showed stronger affinity towards dsRNA reflected in a roughly five- to sixfold higher FLD/UV response ratio compared to ssRNA. This approach consequently also holds promise for the quantitation of dsRNA impurities potentially formed during mRNA synthesis and associated with causing innate immune responses, especially as currently applied methods like immunoassays show several limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.